Skip to content

BioLoquitur

The Life Sciences Patent Blog

Subscribe

Subscribe By Email

Your website url

Stay Connected

RSS Twitter LinkedIn Facebook

Subscribe to this blog Your website url

Recent Updates

Biosimilar IPRs: Timing is Everything . . . But When is The Right Time?
Teva Sues FDA Alleging Unlawful Interpretation of the Definition of “First Applicant”
USPTO Director Proposes New Patent Eligibility Guidance
Tribal Immunity Cannot Be Asserted to Escape IPR Proceedings
FDA Approves First Marijuana-Based Drug to Treat Epilepsy

Topics

ABA Intellectual Property Section
American Chemical Society
American Intellectual Property Law Association
BIO
BioCentutry
Biospace
Biotechnology News — ScienceDaily
BioWorld
California Peculiarities Employment Law Blog
Fierce Biotech
Fierce Pharma
Genetic Engineering News
Patent Trial and Appeal Board (PTAB)
Seyfarth PTAB Blog
Seyfarth Trade Secrets Blog
United States Patent and Trademark Office

RSS Twitter LinkedIn Facebook

Privacy PolicyAttorney Advertising

About

Seyfarth’s Life Sciences attorneys have a deep understanding of the biotechnology, chemical, pharmaceutical, and nanotechnology industries. We represent an international clientele of innovators and investors working with world-changing technologies. Our clients range from clinical-stage biotechnology companies and multinational pharmaceutical corporations to chemical and nanotechnology companies as well as start-up companies and venture capital firms.